MK

Manju Kumari

Active Director Director DIN 08927356
DIN 08927356 First appointment Oct 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Manju Kumari

Data last updated:

Manju Kumari is a Director at Alexi Pharmicia Private Limited (since 2020). The company operates in Pharma. Alexi Pharmicia Private Limited reported revenue of ₹4.37 Cr (FY 2024).

DIN 08927356
Primary Designation Director
Industry Pharma
First Appointment 20 Oct 2020
Oldest Company Age 6 yrs
Largest company Alexi Pharmicia Private Limited · ₹4.37 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alexi Pharmicia Private Limited U24299HP2020PTC008153
Director20 Oct 20202020₹4.37 Cr (FY 2024)Active

Board colleagues of Manju Kumari

NameDINCompanyDesignation
Sudhir Kumar Suman08927354Alexi Pharmicia Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alexi Pharmicia Private Limited
Premium access

Shareholding and investment profile for Manju Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manju Kumari

Manju Kumari currently holds 1 directorship: Alexi Pharmicia Private Limited (Director, since 20 Oct 2020, revenue ₹4.37 Cr (FY 2024)).

Manju Kumari was first appointed on 20 Oct 2020 as Director at Alexi Pharmicia Private Limited.

The current boards of Manju Kumari's companies include Sudhir Kumar Suman (Alexi Pharmicia Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available